company profile is the essential source for top-level company data and information. Menarini Group, The - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
The Menarini Group (Menarini or 'the group'), a privately-held pharmaceutical business entity, is engaged in the development and manufacture of pharmaceutical products mainly for cardiovascular diseases, oncology, and pain, inflammation and asthma. The group primarily operates in Italy. It is headquartered in Florence, Italy and employed 16,603 people at the end of the year 2013. The group recorded revenues of E3,290 million (approximately $4,289.5 million) during the financial year ended December 2013 (FY2013), an increase of 2.4% over FY2012. Menarini has not provided other financial data including operating and net profits.
Scope of the Report
Provides all the crucial information on Menarini Group, The required for business and competitor intelligence needs
Contains a study of the major internal and external factors affecting Menarini Group, The in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Menarini Group, The
Data is supplemented with details on Menarini Group, The history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Menarini Group, The
Reasons to Purchase
Support sales activities by understanding your customers’ businesses better
Understand prospective partners and suppliers
Keep fully up to date on your competitors’ business structure, strategy and prospects
Obtain the most up to date company information available